Community Outreach and Engagement

UK Markey Cancer Center Community Outreach and Engagement programs partner with communities, practitioners and researchers to accelerate health equity and reduce the burden of cancer in the Commonwealth of Kentucky. 

The objectives of Community Outreach and Engagement at Markey are to:

  1. Monitor cancer burden and disparities in Kentucky and identify community-driven priorities.
  2. Foster impactful research that responds to community needs and promotes equity.
  3. Disseminate and implement sustainable evidence-based guidelines, practices and policies.










pam hull

Pamela Hull, PhD

Associate Director for Population Science and Community Impact

Dr. Pamela Hull oversees Markey’s Community Outreach and Engagement (COE) programs and leads integration of COE throughout Markey. Dr. Hull has over 17 years of experience doing community-engaged research together with community partners, including coalitions, community advisory boards, and a wide variety of organizations. As a medical sociologist, she also contributes expertise in implementation science and multilevel interventions. She is committed to working with partners and researchers to ensure that Markey’s research responds to community needs and priorities, to facilitate meaningful involvement of community partners throughout the research process, to enhance the inclusiveness of our outreach and research efforts, and to maximize the beneficial impact of Markey’s research and outreach on the lives of Kentuckians in our common fight against cancer. 

Tim Mullett

Timothy Mullett, MD, MBA

Assistant Director of Community Clinical Engagement

Dr. Mullett oversees COE’s clinical outreach activities through the Markey Cancer Center Affiliate Network (MCCAN), clinical trial referrals from MCCAN hospitals to Markey and facilitates other community-based clinical partnerships. He provides expertise on evidence-based clinical guidelines for cancer care and cancer screening, provider engagement and clinical trials. Dr. Mullett has served as medical director for MCCAN since 2014 and chairs the Markey Cancer Committee. He is a cancer survivor, a national leader in thoracic surgical oncology and chair of the American College of Surgeons Commission on Cancer, where he provides national leadership on the implementation of cancer care quality guidelines. In addition, his research focuses on improving the implementation of clinical guidelines for lung cancer prevention, screening and cancer care.

News and Highlights


2021 KY Cancer Needs Assessment Report
Get the Report


Why We Care Series: Celebrating access to research for Everyone
Watch the video


Markey Cancer Center to host affiliate network conference
Read the story

Markey Cancer Center Catchment Area

As the only NCI-designated cancer center in Kentucky, the Markey Cancer Center defines its catchment area as the entire state. This definition aligns with the University of Kentucky’s land-grant mission as the state’s flagship public university. Markey sees patients from all 120 Kentucky counties and reaches diverse and underserved communities throughout the Commonwealth through partnerships with the Markey Cancer Center Affiliate Network, comprised of community-based hospitals outside of UK Health Care. 

Kentucky has a population of 4.4 million people, with on average over 27,000 new cancer cases and over 10,000 cancer deaths each year. Over 70% of Kentucky’s 120 counties are rural, where 44.1% of Kentuckians live. A quarter of the population lives in 55 Appalachian counties in Eastern Kentucky.

Markey Cancer Center is NCI-designated

The UK Markey Cancer Center was first designated by the National Cancer Institute in 2013 – a distinction that recognizes our extraordinary ability to provide world-class care for our patients. We are the only NCI-Designated Cancer Center in Kentucky and one of only 71 in the nation.